195 related articles for article (PubMed ID: 21385167)
21. Inference for causal interactions for continuous exposures under dichotomization.
VanderWeele TJ; Chen Y; Ahsan H
Biometrics; 2011 Dec; 67(4):1414-21. PubMed ID: 21689079
[TBL] [Abstract][Full Text] [Related]
22. Exact tests using two correlated binomial variables in contemporary cancer clinical trials.
Yu J; Kepner JL; Iyer R
Biom J; 2009 Dec; 51(6):899-914. PubMed ID: 20014199
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification.
Lachin JM; Foulkes MA
Biometrics; 1986 Sep; 42(3):507-19. PubMed ID: 3567285
[TBL] [Abstract][Full Text] [Related]
24. Principal stratification designs to estimate input data missing due to death.
Frangakis CE; Rubin DB; An MW; MacKenzie E
Biometrics; 2007 Sep; 63(3):641-9; discussion 650-62. PubMed ID: 17824995
[TBL] [Abstract][Full Text] [Related]
25. Joint models for efficient estimation in proportional hazards regression models.
Slasor P; Laird N
Stat Med; 2003 Jul; 22(13):2137-48. PubMed ID: 12820279
[TBL] [Abstract][Full Text] [Related]
26. A proportional hazards cure model for the analysis of time to event with frequently unidentifiable causes.
Dahlberg SE; Wang M
Biometrics; 2007 Dec; 63(4):1237-44. PubMed ID: 18078485
[TBL] [Abstract][Full Text] [Related]
27. Correction of confounding bias in non-randomized studies by appropriate weighting.
Schmoor C; Gall C; Stampf S; Graf E
Biom J; 2011 Mar; 53(2):369-87. PubMed ID: 21308726
[TBL] [Abstract][Full Text] [Related]
28. Refined measurement of outcome for adjuvant breast carcinoma therapy.
Gamel JW; Bonadonna G; Valagussa P; Edwards MJ
Cancer; 2003 Mar; 97(5):1139-46. PubMed ID: 12599218
[TBL] [Abstract][Full Text] [Related]
29. Maximum likelihood estimation in survival studies under progressive interval censoring with random removals.
Xiang L; Tse SK
J Biopharm Stat; 2005; 15(6):981-91. PubMed ID: 16279356
[TBL] [Abstract][Full Text] [Related]
30. Analysis of failure time data with multilevel clustering, with application to the child vitamin a intervention trial in Nepal.
Shih JH; Lu SE
Biometrics; 2007 Sep; 63(3):673-80. PubMed ID: 17825001
[TBL] [Abstract][Full Text] [Related]
31. Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer.
Hébert-Croteau N; Brisson J; Lemaire J; Latreille J; Pineault R
Cancer; 2005 Oct; 104(7):1343-8. PubMed ID: 16080144
[TBL] [Abstract][Full Text] [Related]
32. Incidence of advanced symptomatic disease as primary endpoint in screening and prevention trials.
Obuchowski NA; Schoenhagen P; Modic MT; Meziane M; Budd GT
AJR Am J Roentgenol; 2007 Jul; 189(1):19-23. PubMed ID: 17579145
[TBL] [Abstract][Full Text] [Related]
33. Exact, distribution free confidence intervals for late effects in censored matched pairs.
Daniel SR
Biom J; 2009 Feb; 51(1):31-44. PubMed ID: 19219909
[TBL] [Abstract][Full Text] [Related]
34. Bounds on causal effects in randomized trials with noncompliance under monotonicity assumptions about covariates.
Chiba Y
Stat Med; 2009 Nov; 28(26):3249-59. PubMed ID: 19777494
[TBL] [Abstract][Full Text] [Related]
35. A new semiparametric estimation method for accelerated hazard model.
Zhang J; Peng Y; Zhao O
Biometrics; 2011 Dec; 67(4):1352-60. PubMed ID: 21457194
[TBL] [Abstract][Full Text] [Related]
36. Estimation of treatment effect adjusting for dependent censoring using the IPCW method: an application to a large primary prevention study for coronary events (MEGA study).
Yoshida M; Matsuyama Y; Ohashi Y;
Clin Trials; 2007; 4(4):318-28. PubMed ID: 17848493
[TBL] [Abstract][Full Text] [Related]
37. Comment on Nie et al. (2011), biometrics, early view.
Baker SG
Biometrics; 2012 Sep; 68(3):992; author reply 992. PubMed ID: 23013226
[No Abstract] [Full Text] [Related]
38. Marginal analysis of correlated failure time data with informative cluster sizes.
Cong XJ; Yin G; Shen Y
Biometrics; 2007 Sep; 63(3):663-72. PubMed ID: 17825000
[TBL] [Abstract][Full Text] [Related]
39. A modified pseudolikelihood approach for analysis of longitudinal data.
Wang YG; Zhao Y
Biometrics; 2007 Sep; 63(3):681-9. PubMed ID: 17825002
[TBL] [Abstract][Full Text] [Related]
40. Using the instrumental variables estimator to analyze noninferiority trials with noncompliance.
Kim MY
J Biopharm Stat; 2010 Jul; 20(4):745-58. PubMed ID: 20496203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
